Selvita Past Earnings Performance
Past criteria checks 4/6
Selvita has been growing earnings at an average annual rate of 26%, while the Life Sciences industry saw earnings growing at 19.6% annually. Revenues have been growing at an average rate of 41.4% per year. Selvita's return on equity is 8.5%, and it has net margins of 5.9%.
Key information
26.0%
Earnings growth rate
8.6%
EPS growth rate
Life Sciences Industry Growth | 26.0% |
Revenue growth rate | 41.4% |
Return on equity | 8.5% |
Net Margin | 5.9% |
Next Earnings Update | 27 Mar 2024 |
Recent past performance updates
Recent updates
Selvita S.A. (WSE:SLV) Analysts Just Cut Their EPS Forecasts Substantially
Oct 07We Think Selvita (WSE:SLV) Can Stay On Top Of Its Debt
Sep 28Here's Why Selvita (WSE:SLV) Has Caught The Eye Of Investors
Jun 02Selvita (WSE:SLV) Seems To Use Debt Quite Sensibly
Jun 09These 4 Measures Indicate That Selvita (WSE:SLV) Is Using Debt Reasonably Well
Feb 23If You Like EPS Growth Then Check Out Selvita (WSE:SLV) Before It's Too Late
Mar 31Here's What Selvita S.A.'s (WSE:SLV) Shareholder Ownership Structure Looks Like
Feb 25Here's Why We Don't Think Selvita's (WSE:SLV) Statutory Earnings Reflect Its Underlying Earnings Potential
Jan 22Is Now The Time To Put Selvita (WSE:SLV) On Your Watchlist?
Dec 25Did You Miss Selvita's (WSE:SLV) Impressive 113% Share Price Gain?
Dec 02Revenue & Expenses BreakdownBeta
How Selvita makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
---|---|---|---|---|
30 Sep 23 | 410 | 24 | 248 | 0 |
30 Jun 23 | 420 | 35 | 252 | 0 |
31 Mar 23 | 424 | 29 | 258 | 0 |
31 Dec 22 | 416 | 30 | 254 | 0 |
30 Sep 22 | 364 | 20 | 219 | 0 |
30 Jun 22 | 351 | 11 | 220 | 0 |
31 Mar 22 | 329 | 12 | 211 | 0 |
31 Dec 21 | 316 | 15 | 198 | 0 |
30 Sep 21 | 260 | 12 | 162 | 0 |
30 Jun 21 | 216 | 18 | 131 | 0 |
31 Mar 21 | 181 | 22 | 105 | 0 |
31 Dec 20 | 142 | 18 | 85 | 0 |
30 Sep 20 | 158 | 21 | 92 | 0 |
30 Jun 20 | 99 | 15 | 58 | 0 |
31 Mar 20 | 63 | 9 | 36 | 0 |
31 Dec 19 | 54 | 7 | 30 | 0 |
30 Sep 19 | 22 | 2 | 14 | 0 |
31 Mar 19 | 81 | 10 | 49 | 0 |
31 Dec 18 | 77 | 10 | 47 | 0 |
31 Dec 17 | 56 | 4 | 36 | 0 |
Quality Earnings: SLV has high quality earnings.
Growing Profit Margin: SLV's current net profit margins (5.9%) are higher than last year (5.5%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: SLV's earnings have grown significantly by 26% per year over the past 5 years.
Accelerating Growth: SLV's earnings growth over the past year (21.1%) is below its 5-year average (26% per year).
Earnings vs Industry: SLV earnings growth over the past year (21.1%) exceeded the Life Sciences industry 0.4%.
Return on Equity
High ROE: SLV's Return on Equity (8.5%) is considered low.